The U.S. House of Representatives passed President Donald Trump’s tax-cut and spending bill on Thursday, which contains ...

Faruqi & Faruqi, LLP investigates Elevance Health after investors alleged deceptive statements regarding Medicaid costs. The ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

The U.S. House of Representatives passed President Donald Trump's tax-cut and spending bill on Thursday, which contains ...

Centene's 40% drop offers a buying opportunity as valuation becomes attractive. Read why I think CNC stock is now ...

Insurance companies pledged to reduce wait times for prior authorization approvals, with support from Dr Mehmet Oz.

Centene pulled back its guidance for the year after receiving an actuarial report suggesting its growth in the Affordable ...

Other insurers with ACA and Medicaid exposure also were among the top 10 S&P 500 losers, including Molina Healthcare MOH, ...

Centene is also witnessing higher medical costs in its Medicaid business, particularly in areas of behavioral health, home health and high-cost drugs, and in certain areas, including New York and ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Faruqi & Faruqi, LLP is investigating Elevance Health for misleading investors about rising Medicaid costs between April and ...

Wellpoint DC, a subsidiary of Elevance Health, rebrands as Wellpoint DC, focusing on whole health benefits for District ...